한빛사논문
Aseer Intisara,1, Hanwoong Wooa,1, Hyun Gyu Kanga, Woon-Hae Kima,b, Hyun Young Shina,b,c, Min Young Kima, Yu Seon Kimd, Yun Jeoung Mod, Yun-Il Leed, Minseok S. Kima,b,e,f
aDepartment of New Biology, DGIST, Daegu, 42988, Republic of Korea
bCTCELLS Corp., Daegu, 42988, Republic of Korea
cSBCure Corp., Daegu, 43017, Republic of Korea
dWell Aging Research Center, DGIST, Daegu, 42988, Republic of Korea
eTranslational Responsive Medicine Center (TRMC), DGIST, Daegu, 42988, Republic of Korea
fNew Biology Research Center (NBRC), DGIST, Daegu, 42988, Republic of Korea
1Authors contributed equally.
Corresponding author : Minseok S. Kim
Abstract
Charcot-Marie-Tooth disease subtype 1A (CMT1A) is one of the most prevalent demyelinating peripheral neuropathies worldwide, caused by duplication of the peripheral myelin protein 22 (PMP22) gene, which is expressed primarily in Schwann cells (SCs). PMP22 overexpression in SCs leads to intracellular aggregation of the protein, which eventually results in demyelination. Unfortunately, previous biochemical approaches have not resulted in an approved treatment for CMT1A disease, compelling the pursuit for a biophysical approach such as electrical stimulation (ES). However, the effects of ES on CMT1A SCs have remained unexplored. In this study, we established PMP22-overexpressed Schwannoma cells as a CMT1A in vitro model, and investigated the biomolecular changes upon applying ES via a custom-made high-throughput ES platform, screening for the condition that delivers optimal therapeutic effects. While PMP22-overexpressed Schwannoma exhibited intracellular PMP22 aggregation, ES at 20 Hz for 1 h improved this phenomenon, bringing PMP22 distribution closer to healthy condition. ES at this condition also enhanced the expression of the genes encoding myelin basic protein (MBP) and myelin-associated glycoprotein (MAG), which are essential for assembling myelin sheath. Furthermore, ES altered the gene expression for myelination-regulating transcription factors Krox-20, Oct-6, c-Jun and Sox10, inducing pro-myelinating effects in PMP22-overexpressed Schwannoma. While electroceuticals has previously been applied in the peripheral nervous system towards acquired peripheral neuropathies such as pain and nerve injury, this study demonstrates its effectiveness towards ameliorating biomolecular abnormalities in an in vitro model of CMT1A, an inherited peripheral neuropathy. These findings will facilitate the clinical translation of an electroceutical treatment for CMT1A.
논문정보
관련 링크
연구자 키워드
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기